SARomics Biostructures and Vipergen Offer DEL-based drug discovery services
SARomics Biostructures AB and Vipergen ApS partner to offer hit and lead identification services based on Vipergen’s DEL screening technology.
SARomics Biostructures AB and Vipergen ApS partner to offer hit and lead identification services based on Vipergen’s DEL screening technology.
In this article, we will discuss some significant publications and company activities in 2023. The publications showcase our expertise in the three main areas of our services: X-ray crystallography, NMR spectroscopy, and integrated drug discovery.
Which strategy to choose when planning a drug discovery project? Maybe structure-based design, ligand-based design, or de novo design? These questions are discussed in our series on structure-based drug design in this second post.
Applying structural biology methods requires many different skills and experience. A structural biology services company technology platform brings together all experimental methods and people with the skills required to run a structure-based drug discovery project.